PTHLH and lung cancer: In mice inoculated with highly metastatic breast and lung cancer cell lines, treatment with an anti-PTHrP antibody, reduced both tumour burden and osteoclastic bone resorption (Guise et al, 1996; Iguchi et al, 1996).